Hologic Inc. (NASDAQ:HOLX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Friday. According to Zacks, “Hologic ended third-quarter fiscal 2016 on an encouraging note, with both its top and bottom line comfortably surpassing the Zacks Consensus Estimate. We are impressed to note that […]
